This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (103)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert N. Fernandez, MD; John M. Daly, MD

Arch Surg. 1980;115(4):409-414.

Abstract
• Thirty-eight patients with pseudomyxoma peritonei were treated at the M. D. Anderson Hospital, Houston, from 1954 to 1978. The various treatment regimens used have provided actuarial survival rates of 54% at five years and 18% at ten years. Local or regional disease was the cause of death in 68% of patients, and no patient died of metastatic disease. Initial definitive surgery should consist of effective tumor reduction, omentectomy, appendectomy, and, in the female subject, bilateral oophorectomy. Most patients have been treated adjunctively with either fluorouracil or melphalan (L-phenylalanine mustard) depending on the presumed site of origin, but results in a small number of patients treated with either whole abdominal or strip abdominal radiotherapy suggest that this modality may offer improved survival. Treatment with adjunctive radiotherapy alone has provided a five-year survival rate of 75%, compared with 44% for chemotherapy.

(Arch Surg 115:409-414, 1980)

Author Affiliations
From the Department of Surgery, the University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Tex. Dr Fernandez is now in private practice.

Footnotes
Accepted for publication Dec 14, 1979.

Read before the 87th annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 12, 1979.

Reprint requests to 11245 Huron St, Denver, CO 80234 (Dr Fernandez).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?